The question of putative mechanisms of action continues to haunt psychopharmacology. Put simply, we know these drugs work, but we have very little idea how. We make guesses based on the neurochemical ...
The Company is scheduling a meeting with the FDA to discuss the issues raised in the letter. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Defender ...